| 前收市價 | 8.50 |
| 開市 | 8.57 |
| 買盤 | 8.69 x 100 |
| 賣出價 | 8.73 x 600 |
| 今日波幅 | 8.46 - 8.88 |
| 52 週波幅 | 2.74 - 12.00 |
| 成交量 | |
| 平均成交量 | 2,005,584 |
| 市值 | 1.922B |
| Beta 值 (5 年，每月) | 1.61 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.46 |
| 業績公佈日 | 2024年5月06日 - 2024年5月10日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 11.17 |
Insider Monkey14 Stocks With Heavy Insider Buying In 2024
In this article, we will take a detailed look at 14 Stocks With Heavy Insider Buying In 2024. For a quick overview of such stocks, read our article 5 Stocks With Heavy Insider Buying In 2024. Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months […]
InvestorPlace7 High-Potential Penny Stocks in the Biotech Sector
Most of the biggest biotech stocks on the market started off as unknown penny stocks. Look at Axsome Therapeutics (NASDAQ:AXSM), for example. At one time, it was a $2.50 stock. Now it’s up to $71 with a treatment for major depressive disorder. Fate Therapeutics (NASDAQ:FATE) once traded at less than $2.50, and ran to more than $114. Novavax (NASDAQ:NVAX) once traded around $3. All of them started small, but their strong pipelines didn’t let them stay cheap for long. In fact, find a biotech with
